Revenue at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported revenue of $65.84M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s revenue changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s revenue increased by 40.5% year-over-year, from $46.85M to $65.84M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s revenue?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s revenue has grown at a -30.6% compound annual growth rate (CAGR), from $799.24M to $185.74M.